NTH — Naturhouse Health SA Income Statement
0.000.00%
- €151.67m
- €139.64m
- €47.63m
Annual income statement for Naturhouse Health SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 57.6 | 52.4 | 50.4 | 49.4 | 47.6 |
| Cost of Revenue | |||||
| Gross Profit | 41.3 | 37.5 | 36.7 | 35.5 | 34.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 40.3 | 39.6 | 34.7 | 36.7 | 34.2 |
| Operating Profit | 17.3 | 12.9 | 15.8 | 12.7 | 13.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 18.2 | 13.1 | 15.4 | 13.5 | 13.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 13.4 | 9.62 | 11.2 | 9.86 | 10.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 13.4 | 9.63 | 11.3 | 9.86 | 10.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 13.4 | 9.63 | 11.3 | 9.86 | 10.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.225 | 0.16 | 0.195 | 0.17 | 0.166 |
| Dividends per Share |